About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

Parexel Showcases Oncology Expertise at ASCO 2025; Company Selected to Present Five Posters at World’s Largest Oncology Event

  • Parexel also launching a comprehensive Radiopharmaceuticals report at the meeting
  • Onsite Parexel experts include recently appointed Chief Medical Officer and veteran oncologist Dr. Charlotte Moser, licensed medical oncologist and Global Therapeutic Area Head, Oncology, Dr. Gwyn Bebb, and Global Therapeutic Area Head, Hematology, Dr. Scott Smith

DURHAM, N.C., May 29, 2025 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services, today announced the company will present five posters highlighting key research findings at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting May 30-June 3 in Chicago. Oncologist and newly appointed Chief Medical Officer, Charlotte Moser, M.D., Ph.D., MBA, along with licensed medical oncologist and Senior Vice President and Global Therapeutic Area Head, Oncology, Gwyn Bebb, M.D., Ph.D. and Senior Vice President and Global Therapeutic Area Head, Hematology, Scott Smith, M.D., Ph.D., will attend the meeting. They will be joined by members of the company’s expert Oncology and Hematology team to share insights gained from work supporting 760+ clinical projects, enrolling 107,800+ patients and collaborating with 32,700+ investigative sites over the last five years.

Parexel’s thought leadership poster presentations represent the company’s proven breadth and depth in oncology and hematology, from real-world data analysis of CAR-T procedures to regulatory guidance for theragnostic radiopharmaceuticals. Selected posters include:

  • “A real-world data claims-based review of CAR-T procedures, time to adverse events, patient characteristics, and social factors”
    First author: Karina D'Angelo
    Date and time: Saturday, May 31 from 2:30 p.m. – 5:30 p.m.​
    Poster board #502
  • “Antibody-drug conjugates and pneumonitis risk in breast cancer patients”
    First author: Anna Franklin, M.D.
    Online publication only
  • “Impact of venous thromboembolism on survival in multiple myeloma patients receiving bispecific antibody therapy: Insights from real-world data”
    First author: Vladimir Otasevic, M.D., Ph.D.
    Date and time: Sunday, June 1 from 9:00 a.m. – 12:00 p.m.​
    Poster board #89
  • “Risk of tumor lysis syndrome (TLS) associated with kinase inhibitors: Analysis of FAERS and real-world data”
    First author: Kausik Maiti
    Online publication only
  • “Voids in regulatory guidance for development of theragnostic radiopharmaceuticals in oncology”
    First author: Aaron Sosa, M.D.
    Online publication only

Parexel is also launching its latest report, "Advancing radiopharmaceutical development," in conjunction with ASCO. This comprehensive guide addresses challenges, opportunities and strategies for pharmaceutical and biotech customers developing radiopharmaceuticals, particularly in precision oncology and theranostics. Parexel will feature the report at Booth #12069 during the meeting.

"We are at a pivotal moment in oncology research where groundbreaking technologies like radiopharmaceuticals, CAR-T therapies and precision medicine are reshaping the landscape of cancer treatment," said Dr. Charlotte Moser. "Parexel’s presence at ASCO 2025 reflects our commitment to leading in this exciting period of innovation and supporting our customers in developing and delivering these life-saving treatments for patients.”

For more information about Parexel's presence at ASCO 2025 or to schedule a meeting, please visit https://www.parexel.com/about-us/events/asco-2025.   

About Parexel
Parexel is among the world’s largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, our team of more than 24,000 global professionals works in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind, increasing access and participation to make clinical research a care option for anyone, anywhere. Our depth of industry knowledge and strong track record gained over the past 40 years is moving the industry forward and advancing clinical research in healthcare’s most complex areas, while our innovation ecosystem offers quality solutions to make every phase of the clinical trial process more efficient. With the people, insight and focus on operational excellence, we work With Heart™ every day to treat patients with dignity and continuously learn from their experiences, so every trial makes a difference. This approach continues to earn us recognition industrywide, with Parexel being the recipient of the 2024 and 2023 Society for Clinical Research Sites (SCRS) Eagle Award for advancing the clinical research profession through strong site partnerships, named “Best Contract Research Organization” in November 2023 by an independent panel for Citeline, and “Top CRO to Work With” by investigative sites worldwide in the 2023 WCG CenterWatch Global Site Relationship Benchmark Survey. For more information, visit parexel.com and follow us on LinkedInXFacebook and Instagram.

MEDIA

Danaka Williams
+1 984 298 4207
Danaka.Williams@parexel.com


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.